Newsroom

LAS VEGAS--(BUSINESS WIRE)--SMK Electronics Corporation, USA to Introduce New Automotive In-Cab Illumination Lamps at CES 2026...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Low Duration Global Government Bond UCITS ETF 05.01.2026 FGOV LN IE00BKS2X200 33,638.00 GBP 497,725.95 17.071  ...

NEW YORK--(BUSINESS WIRE)--American International Group, Inc. (NYSE: AIG) today announced that Chairman & CEO Peter Zaffino has informed the AIG Board of Directors that he intends to transition to Executive Chair of AIG and retire as CEO by mid-year after successfully leading the company’s transformation and strategic repositioning as a leading global property and casualty insurer. In alignment with the company’s comprehensive multi-year succession planning process, the Board conducted a se...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific launches CorEvitas Obesity Registry to advance real-world evidence in treatment outcomes....

LEXINGTON, Ky.--(BUSINESS WIRE)--Valvoline Inc. (NYSE: VVV), the quick, easy, trusted leader in preventive automotive maintenance, today announced the launch of its “Instant Transfer Portal,” a new marketing campaign designed to invite drivers to “transfer” from their current oil change provider and receive an instant oil change offer. The Instant Transfer Portal takes inspiration from the energy and language of the college sports transfer portal, reimagining it for everyday vehicle care. The c...

TAMPA, FL--(BUSINESS WIRE)--Kforce Inc. (NYSE: KFRC), a provider of professional staffing services and solutions, will release fourth quarter results post-market on Monday, February 2, 2026, followed by a conference call at 5:00 pm ET to discuss the results. The dial-in number is (800) 715-9871 and the conference passcode is “Kforce”. A replay of the call will be available on our website at https://investor.kforce.com for one year after the call. About Kforce Inc. Kforce Inc. (the “Firm”) is a...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cartography Biosciences, Inc., a biotechnology company advancing a differentiated pipeline of antibody-based cancer therapies, today announced a strategic collaboration with Pfizer to discover tumor-selective antigens. Under the multi-year agreement, Cartography will apply its proprietary ATLAS and SUMMIT discovery platforms to identify and validate tumor-selective antigens in an undisclosed indication. Pfizer may opt in on multiple antigens identif...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that it will participate in and present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Monday, January 12, 2026 at 9:45 AM PT. Robert W. Duggan, Chairman and Co-Chief Executive Officer, and Dr. Maky Zanganeh, President and Co-Chief Executive Officer, will present a corporate overview and a new update on the progress of our organization, includ...

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has approved the supplemental New Drug Application (sNDA) for AUGTYRO™ (repotrectinib) for the treatment of adult patients with solid tumors that harbor a neurotrophic tyrosine receptor kinase (NTRK) gene fusion. The approval is intended for patients whose disease is locally advanced or metastatic, or where surgical resection is li...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from two Phase 1/2a clinical trials of ARO-INHBE and ARO-ALK7, the company’s investigational RNA interference (RNAi) therapeutics being developed as potential treatments for obesity. Preliminary results with Arrowhead’s promising new approach to treating obesity and metabolic diseases showed meaningful reductions in multiple key measures, including visceral fat, total fat, and liver...